Dr. Adilia M. Hormigo, MD, PhD
- Medicare services, 2024
- 70
- Medicare patients, 2024
- 18
- Publications
- 13
- Clinical trials
- 7
- MIPS score, 2024
- 100
- Practice address
- 1695 Eastchester Road, Bronx, NY 10461
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Montefiore Medical Park - Oncology/Pharm/East - HOPD
Acute Care Hospital outpatient department · Bronx, New York
Find Dr. Hormigo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Adilia M. Hormigo is a neurologist in Bronx, New York
Dr. Hormigo practices at Montefiore Medical Park - Oncology/Pharm/East - HOPD in Bronx, New York.
Dr. Hormigo's NPI, 1427029461, was assigned on January 28, 2006. Dr. Hormigo graduated from University of Lisbon Faculty of Medicine in 1981. Dr. Hormigo holds New York license 226250.
- NPI
- 1427029461NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0840284139
- NPI enumeration date
- January 28, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Adilia M. Hormigo practices at Montefiore Medical Park - Oncology/Pharm/East - HOPD in Bronx, New York
Dr. Hormigo's primary practice is Montefiore Medical Park - Oncology/Pharm/East - HOPD, at 1695 Eastchester Road, Bronx, NY 10461.
- Montefiore Medical Park - Oncology/Pharm/East - HOPD1695 Eastchester Road, Bronx, NY 10461
Source: Dmand AI Affiliation Data
Dr. Adilia M. Hormigo is affiliated with 3 sites of care and 3 medical groups
Dr. Hormigo's primary practice is Montefiore Medical Park - Oncology/Pharm/East - HOPD in Bronx, New York. Dr. Hormigo is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Hormigo to 1 more hospital and 2 medical groups, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Adilia M. Hormigo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hormigo practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Montefiore Medical Park - Oncology/Pharm/East - HOPD | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Adilia M. Hormigo is one of 1,489 neurologists in New York
Neurology is Dr. Hormigo's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hormigo is licensed in New York.
Specialties and state licenses
- Neurology, New YorkPrimary
Neurologists near Dr. Hormigo
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Adilia M. Hormigo billed Medicare for 70 services in 2024
CMS data shows 70 Medicare services from Dr. Hormigo across 2 procedure codes in 2024, all of them office visits, for 18 Medicare patients. Medicare paid $8,081 for them. Every service was in an office.
Dr. Hormigo's Medicare services by type, 2021 to 2024
- 2021
- 2024
- Office and hospital visits
- 2021: 972024: 7028%
Dr. Hormigo compared with the New York median for neurologists, 2024
- Dr. Hormigo
- New York median
- Medicare services
- 70vs 37681% below
- Medicare patients
- 18vs 19091% below
Medians across 1,462 neurologists in New York with Dmand AI profiles that report each measure.
Dr. Hormigo's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Hormigo?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hormigo and other neurologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Adilia M. Hormigo treated 18 Medicare patients in 2024, average age 66
CMS counts 18 Medicare patients who saw Dr. Hormigo in 2024. 75% of them have high blood pressure, and 61% have arthritis. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Hormigo's median patient age at 54, with 63% women.
Chronic conditions among Dr. Hormigo's Medicare patients, 2024
- High blood pressure75%
- Arthritis61%
- High cholesterol61%
Share of Medicare patients with each condition. A patient can have several.
Dr. Hormigo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 54
Patient panel by sex, all payers
- Women63%
- Men38%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Adilia M. Hormigo scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hormigo for performance year 2024, reported as part of a group.
Dr. Hormigo's MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Adilia M. Hormigo has 13 publications on record
Dmand AI links 13 papers to Dr. Hormigo, published from 2012 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Brain Neoplasms, Glioblastoma and Biopsy. Dr. Hormigo has published most often in Cancers (Basel). Dr. Hormigo's most frequent co-authors are Kambiz Nael, MD, Antonio Marcilio Padula Omuro, MD and Craig P. Nolan, MD.
Dr. Hormigo's papers by year, 2012 to 2024
Topics Dr. Hormigo writes about most
- Brain Neoplasms
- Glioblastoma
- Biopsy
- DNA Mutational Analysis
- Magnetic Resonance Imaging
- Radiosurgery
- Temozolomide
- Tumor Microenvironment
Dr. Hormigo's most frequent co-authors
- Kambiz Nael, MD4 shared papers
- Antonio Marcilio Padula Omuro, MD4 shared papers
- Craig P. Nolan, MD3 shared papers
Recent publications by Dr. Hormigo
J Transl Med
See who Dr. Hormigo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hormigo works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Adilia M. Hormigo has worked on 7 clinical trials
Dmand AI links Dr. Hormigo to 7 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Gliosarcoma.
Clinical trials with Dr. Hormigo by phase
- 2Phase 1: 2 trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Hormigo's trials
- Glioblastoma
- Astrocytoma
- Gliosarcoma
- Meningioma
- Meningeal Neoplasms
Investigators on the most trials with Dr. Hormigo
- Edward Pan, MD4 shared trials
- Nicholas George Avgeropoulos, MD3 shared trials
- Jan Drappatz3 shared trials
Recent clinical trials with Dr. Hormigo
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation (opens in a new tab)
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma (opens in a new tab)
Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients With Newly Diagnosed Glioblastoma (GCO 17-0566) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Adilia M. Hormigo received $391 in industry payments in 2019
CMS Open Payments shows 4 general payments to Dr. Hormigo from 3 drug and device companies in 2019. Food and beverage make up the largest share, 100% of the total. Agios Pharmaceuticals, Inc. paid the most, $185.
Companies that paid Dr. Hormigo the most, 2019 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Adilia M. Hormigo graduated from University of Lisbon Faculty of Medicine
Dr. Hormigo graduated from University of Lisbon Faculty of Medicine in 1981.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Adilia M. Hormigo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Adilia M. Hormigo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Adilia M. Hormigo's NPI number?
Dr. Adilia M. Hormigo's NPI number is 1427029461. It was assigned on January 28, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Adilia M. Hormigo?
Dr. Adilia M. Hormigo is a neurologist in Bronx, New York. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Adilia M. Hormigo practice?
Dr. Hormigo practices at 1695 Eastchester Road, Bronx, NY 10461. Dr. Hormigo's primary practice is Montefiore Medical Park - Oncology/Pharm/East - HOPD in Bronx, New York. Dmand AI also links Dr. Hormigo to 1 hospital and 2 medical groups.
What is Dr. Adilia M. Hormigo's medical license number?
Dr. Hormigo holds New York license 226250.
Which hospitals is Dr. Adilia M. Hormigo affiliated with?
Dr. Hormigo is affiliated with Montefiore Einstein Hospital-Moses Campus. Dmand AI links Dr. Hormigo to 1 more hospital.
What medical group is Dr. Adilia M. Hormigo part of?
Dr. Hormigo is linked to Montefiore Einstein Faculty Practice Group. Dmand AI links Dr. Hormigo to 2 more medical groups.
Does Dr. Adilia M. Hormigo accept Medicare?
Yes. CMS data shows Dr. Hormigo billed Medicare for 70 services in 2024.
What is Dr. Adilia M. Hormigo's MIPS score?
Dr. Hormigo's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
How many Medicare patients does Dr. Adilia M. Hormigo see?
CMS counts 18 Medicare patients who saw Dr. Hormigo in 2024, with an average age of 66.
What services does Dr. Adilia M. Hormigo bill to Medicare?
In 2024, Dr. Hormigo's most billed Medicare services were office visit, established patient (99215) and office visit, established patient (99214).
Show 5 more questionsShow fewer questions
Where did Dr. Adilia M. Hormigo go to medical school?
Dr. Hormigo graduated from University of Lisbon Faculty of Medicine in 1981.
Has Dr. Adilia M. Hormigo received payments from drug or device companies?
CMS Open Payments shows $391 in general payments to Dr. Hormigo from 3 companies from 2019 to 2019. The largest total came from Agios Pharmaceuticals, Inc.
How long has Dr. Adilia M. Hormigo been practicing?
Dr. Hormigo graduated from medical school in 1981, 45 years ago.
Does Dr. Adilia M. Hormigo do research?
Dmand AI links 13 publications to Dr. Hormigo, published from 2012 to 2024. Dr. Hormigo has worked on 7 clinical trials.
Who does Dr. Adilia M. Hormigo publish with?
Dr. Hormigo's most frequent co-authors are Kambiz Nael, MD (4 shared papers), Antonio Marcilio Padula Omuro, MD (4 shared papers) and Craig P. Nolan, MD (3 shared papers).
Selling to neurology practices?
See neurologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card